Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 66 Total
FUV - Arcimoto Inc - Stock Price Chart
TickerFUV [NASD]
CompanyArcimoto Inc
CountryUSA
IndustryRecreational Vehicles
Market Cap3.78MEPS (ttm)-9.64
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-42.75%
P/S0.57EPS next 5Y-
P/B0.50EPS Q/Q79.05%
Dividend-Sales Q/Q-45.15%
Insider Own14.03%Inst Own13.06%
Insider Trans0.00%Inst Trans0.96%
Short Float11.42%Earnings-
Analyst Recom1.00Target Price4.00
Avg Volume61.50K52W Range0.40 - 1.85
Arcimoto, Inc. engages in the design, development, manufacture, sale, and rental of three-wheeled electric vehicles. Its products include Fun Utility Vehicle, Rapid Responder, Deliverator, Cameo, Flatbed, Mean Lean Machine, and Roadster. It operates through the following segments: Fun Utility Vehicles (FUV), Rental, and TMW. The FUV segment includes the sale of electric vehicle product lines. The Rental segment is involved in short-term rental of electric vehicles via various channels or networks. The TMW segment engages in the design, production, sales, and installation of a bolt on kit that converts a two wheeled motorcycle into a tilting three wheeled motorcycle. The company was founded by Mark D. Frohnmayer on November 21, 2007 and is headquartered in Eugene, OR.
OGEN - Oragenics Inc - Stock Price Chart
TickerOGEN [AMEX]
CompanyOragenics Inc
CountryUSA
IndustryBiotechnology
Market Cap4.52MEPS (ttm)-7.90
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y29.34%
P/S113.12EPS next 5Y-
P/B1.98EPS Q/Q-356.71%
Dividend-Sales Q/Q-
Insider Own11.83%Inst Own1.39%
Insider Trans-0.66%Inst Trans28.33%
Short Float0.90%Earnings-
Analyst Recom1.00Target Price90.00
Avg Volume99.79K52W Range1.01 - 7.74
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Telling FredDirectorNov 30 '23Sale3.573,50012,48838,345Dec 01 05:23 PM
DALN - DallasNews Corporation - Stock Price Chart
TickerDALN [NASD]
CompanyDallasNews Corporation
CountryUSA
IndustryPublishing
Market Cap19.10MEPS (ttm)-1.33
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.21%
P/S0.14EPS next 5Y-
P/B6.46EPS Q/Q-3.07%
Dividend17.93%Sales Q/Q-13.09%
Insider Own18.36%Inst Own24.72%
Insider Trans0.00%Inst Trans-5.56%
Short Float2.17%EarningsMar 07/b
Analyst Recom-Target Price-
Avg Volume35.66K52W Range3.55 - 5.13
DallasNews Corp. is a news and information publishing company, which owns and operates commercial printing, distribution, and direct mail service businesses. It operates through the following segments: Publishing and Marketing. The Publishing segment includes the operations of The Dallas Morning News and various niche publications targeting specific audiences. The Marketing segment focuses on the marketing services generated by DMV Holdings and its subsidiaries, Distribion, Vertical Nerve, and MarketingFX. The company was founded on April 11, 1842 and is headquartered in Dallas, TX.
LSDI - Lucy Scientific Discovery Inc - Stock Price Chart
TickerLSDI [NASD]
CompanyLucy Scientific Discovery Inc
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.36MEPS (ttm)-0.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S68.20EPS next 5Y-
P/B168.48EPS Q/Q-78.19%
Dividend-Sales Q/Q-
Insider Own36.91%Inst Own7.18%
Insider Trans0.00%Inst Trans-
Short Float1.70%Earnings-
Analyst Recom1.00Target Price14.00
Avg Volume47.37K52W Range0.72 - 17.00
Lucy Scientific Discovery, Inc. is an early-stage company, which engages in the manufacture of psychotropics contracts. It focuses on the research, development, and manufacture of psychotropics-based medicines. Its products include raw materials, crude extracts, targeted formulations, white and private label products, and single molecule fractions. The company was founded on February 17, 2017 and is headquartered in Victoria, Canada.
EGRX - Eagle Pharmaceuticals Inc - Stock Price Chart
TickerEGRX [NASD, RUT]
CompanyEagle Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap52.61MEPS (ttm)0.91
P/E4.45EPS this Y-
Forward P/E-EPS next Y-
PEG1.65EPS past 5Y-3.56%
P/S0.20EPS next 5Y2.70%
P/B0.21EPS Q/Q153.33%
Dividend-Sales Q/Q-12.80%
Insider Own12.02%Inst Own86.94%
Insider Trans-1.37%Inst Trans-1.47%
Short Float10.30%EarningsNov 16/b
Analyst Recom3.00Target Price17.00
Avg Volume180.41K52W Range4.05 - 30.40
Apr-15-24 07:00AM Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida (GlobeNewswire) +13.29%
Apr-12-24 04:05PM Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K (GlobeNewswire)
Feb-05-24 09:55AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Feb-01-24 04:05PM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Jan-26-24 12:33PM EGRX STOCKHOLDERS: Robbins LLP Reminds Eagle Pharmaceuticals Shareholders of Pending Lead Plaintiff Deadline February 9, 2024 (GlobeNewswire)
Jan-24-24 09:45AM EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-18-24 06:50AM Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio (GlobeNewswire)
Jan-12-24 10:12AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Jan-10-24 10:00AM EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-08-24 05:43PM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tarriff ScottCEONov 02 '23Sale13.8710,694148,326545,447Nov 03 04:39 PM
Tarriff ScottCEONov 01 '23Sale13.8210,925150,984556,141Nov 03 04:39 PM
Graves MichaelDirectorOct 27 '23Option Exercise4.949,36046,23810,360Oct 31 05:41 PM
Tarriff ScottCEOOct 03 '23Sale14.4610,734155,174567,066Oct 04 05:07 PM
Tarriff ScottCEOOct 02 '23Sale15.239,511144,853577,800Oct 04 05:07 PM
ZIP - ZipRecruiter Inc - Stock Price Chart
TickerZIP [NYSE, RUT]
CompanyZipRecruiter Inc
CountryUSA
IndustryStaffing & Employment Services
Market Cap1.04BEPS (ttm)0.47
P/E22.38EPS this Y-118.11%
Forward P/E75.83EPS next Y265.27%
PEG2.17EPS past 5Y-
P/S1.61EPS next 5Y10.30%
P/B123.32EPS Q/Q-67.13%
Dividend-Sales Q/Q-35.42%
Insider Own30.23%Inst Own49.70%
Insider Trans-0.98%Inst Trans-1.83%
Short Float4.77%EarningsMay 09/a
Analyst Recom2.38Target Price14.20
Avg Volume544.97K52W Range10.27 - 19.29
ZipRecruiter, Inc. operates as web-based hiring platform for small and medium sized businesses. It streamlines the hiring process and offers reseller programs, ATS integrations, and email alert program. The company was founded by Ian Siegel, Joe Edmonds, Ward Poulos, and Willis Redd in 2010 and is headquartered in Santa Monica, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YARBROUGH TIMOTHY G.EVP & CHIEF FINANCIAL OFFICERApr 19 '24Sale10.476,01362,937180,682Apr 22 04:55 PM
SAKAMOTO RYAN T.EVP, CHIEF LEGAL OFFICERApr 19 '24Sale10.471,35714,20396,192Apr 22 04:54 PM
SHIMANOVSKY BORIS F.EVP & CHIEF TECHNOLOGY OFFICERMar 21 '24Sale12.005,20062,400224,182Mar 21 08:37 PM
TRAVERS DAVIDPRESIDENTMar 21 '24Sale11.8884910,0871,086,401Mar 21 08:35 PM
TRAVERS DAVIDPRESIDENTMar 20 '24Sale11.7431,621371,1801,086,401Mar 21 08:35 PM
TRIB - Trinity Biotech Plc ADR - Stock Price Chart
TickerTRIB [NASD]
CompanyTrinity Biotech Plc ADR
CountryIreland
IndustryDiagnostics & Research
Market Cap13.60MEPS (ttm)-6.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-24.31%
P/S0.24EPS next 5Y15.00%
P/B-EPS Q/Q-171.34%
Dividend-Sales Q/Q-25.55%
Insider Own3.57%Inst Own39.26%
Insider Trans0.00%Inst Trans-9.83%
Short Float0.03%EarningsApr 04/b
Analyst Recom1.00Target Price20.00
Avg Volume97.37K52W Range1.79 - 5.50
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.
JOUT - Johnson Outdoors Inc - Stock Price Chart
TickerJOUT [NASD, RUT]
CompanyJohnson Outdoors Inc
CountryUSA
IndustryLeisure
Market Cap417.17MEPS (ttm)1.72
P/E23.91EPS this Y-9.47%
Forward P/E11.72EPS next Y103.49%
PEG1.71EPS past 5Y-14.37%
P/S0.67EPS next 5Y14.00%
P/B0.83EPS Q/Q-33.07%
Dividend3.17%Sales Q/Q-22.26%
Insider Own18.23%Inst Own66.47%
Insider Trans0.00%Inst Trans-1.60%
Short Float4.58%EarningsMay 03/b
Analyst Recom1.00Target Price117.00
Avg Volume46.59K52W Range41.16 - 64.71
Johnson Outdoors, Inc. engages in the manufacturing and marketing of seasonal, outdoor recreation products. It operates through the following segments: Fishing, Camping, Watercraft Recreation, Diving, and Other. The Fishing segment includes the brands Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers, and shallow water anchors, Humminbird sonar and GPS equipment for fishfinding, navigation and marine cartography, and Cannon downriggers for controlled-depth fishing. The Camping segment consists of Eureka! Consumer, commercial and military tents and accessories, sleeping bags, camping furniture and stoves and other recreational camping products, and Jetboil portable outdoor cooking systems. The Watercraft Recreation segment designs and markets canoes and kayaks, including pedal-driven and Minn Kota motor-driven kayaks, under the Ocean Kayaks and Old Town brand names for family recreation, touring, angling, and tripping. The Diving segment sells and distributes the SCUBAPRO brand. The company was founded by Samuel Curtis Johnson II in 1970 and is headquartered in Racine, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson David WVice President and CFOSep 13 '23Sale54.851,00054,85026,857Sep 13 12:19 PM
Johnson David WVice President and CFOJun 12 '23Sale60.041,00060,04027,857Jun 13 11:03 AM
FAHEY JOHN M JRDirectorJun 02 '23Sale58.501,27974,82616,509Jun 05 11:14 AM
CCSI - Consensus Cloud Solutions Inc - Stock Price Chart
TickerCCSI [NASD, RUT]
CompanyConsensus Cloud Solutions Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap240.12MEPS (ttm)3.94
P/E3.17EPS this Y0.38%
Forward P/E2.36EPS next Y3.66%
PEG-EPS past 5Y-12.26%
P/S0.66EPS next 5Y-
P/B-EPS Q/Q7.52%
Dividend-Sales Q/Q-2.75%
Insider Own8.12%Inst Own97.09%
Insider Trans0.00%Inst Trans7.06%
Short Float3.47%EarningsMay 08/a
Analyst Recom2.33Target Price23.80
Avg Volume404.39K52W Range12.25 - 38.34
Consensus Cloud Solutions, Inc. provides digital cloud fax technology, with a scalable software-as-a-service (SaaS) platform. Its products and solutions include eFax Corporate, Unite, jSign, Signal, Clarity and eFax. The company was founded on May 24, 2021 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MALONE JAMES CChief Financial OfficerMay 11 '23Buy33.984,500152,91017,091May 12 04:30 PM
SEEL - Seelos Therapeutics Inc - Stock Price Chart
TickerSEEL [NASD]
CompanySeelos Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap3.83MEPS (ttm)-8.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y62.30%
P/S1.74EPS next 5Y-
P/B-EPS Q/Q89.34%
Dividend-Sales Q/Q-
Insider Own8.70%Inst Own14.97%
Insider Trans15.39%Inst Trans-50.99%
Short Float5.48%Earnings-
Analyst Recom1.00Target Price4.00
Avg Volume441.30K52W Range0.28 - 49.80
Apr-29-24 08:00AM Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations (PR Newswire)
Mar-22-24 01:53PM SEEL Stock Earnings: Seelos Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
Mar-19-24 08:43AM UPDATE 2-Seelos Therapeutics' ALS treatment fails mid-stage study (Reuters) -29.18%
08:23AM Seelos says ALS treatment fails in mid-stage study (Reuters)
08:15AM Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose) (PR Newswire)
Jan-26-24 08:30AM Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules (PR Newswire)
Jan-24-24 09:00AM How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition (PR Newswire) -10.74%
Jan-22-24 08:00AM Seelos Therapeutics Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration (FDA) Highlighting Modifications to the Primary and Secondary Endpoints of its Phase II Study of SLS-002 (PR Newswire)
Jan-09-24 01:56PM Therapys New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution (InvestorPlace) +25.17%
Jan-02-24 08:00AM Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote 'FOR' All Proxy Proposals at the Special Meeting to be held on January 10, 2024 (PR Newswire)
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mehra RajSee RemarksDec 01 '23Buy1.3275,75799,999185,142Dec 01 04:16 PM
Golembiewski Michael JosephChief Financial OfficerNov 30 '23Buy1.2183,000100,22286,450Dec 01 04:16 PM
1234567